We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
19 January 2023
The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys AG, a clinical-stage company based in Basel, Switzerland. The transaction marks the Fund's first investment in Europe and is an important step toward building an international portfolio of companies that are de-veloping urgently needed antimicrobials. BioVersys AG is focusing on research and develop-ment of therapies for life-threatening multidrug-resistant bacterial infections and targeted mi-crobiome modulation. With this investment, BioVersys AG extended its Series C investment round to CHF 32.6m. VISCHER AG advised AMR Action Fund with a team lead by Matthias Staehelin with Sebastian Flückiger, Balthasar Müller and Natacha Tang (all Corporate/M&A).
Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch...
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation...
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional...